These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35601615)

  • 1. Pallidal Structural Changes Related to Levodopa-induced Dyskinesia in Parkinson's Disease.
    Youn J; Kim M; Park S; Kim JS; Park H; Cho JW
    Front Aging Neurosci; 2022; 14():781883. PubMed ID: 35601615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varying time-course of effects of high frequency stimulation of sub-regions of the globus pallidus in patients with parkinson's disease.
    Angeli A; Akram H; Zacharia A; Limousin P; Hariz M; Zrinzo L; Foltynie T
    Parkinsonism Relat Disord; 2015 Jun; 21(6):597-602. PubMed ID: 25842261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal Cortico-Basal Ganglia Neurotransmission in a Mouse Model of l-DOPA-Induced Dyskinesia.
    Dwi Wahyu I; Chiken S; Hasegawa T; Sano H; Nambu A
    J Neurosci; 2021 Mar; 41(12):2668-2683. PubMed ID: 33563724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pallidal versus subthalamic nucleus deep brain stimulation for levodopa-induced dyskinesia.
    Fan SY; Wang KL; Hu W; Eisinger RS; Han A; Han CL; Wang Q; Michitomo S; Zhang JG; Wang F; Ramirez-Zamora A; Meng FG
    Ann Clin Transl Neurol; 2020 Jan; 7(1):59-68. PubMed ID: 31813194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Globus pallidus, but not entopeduncular nucleus, 6-OHDA-induced lesion attenuates L-Dopa-induced dyskinesia in the rat model of Parkinson's disease.
    Marin C; Bonastre M; Fuentes M; Mullol J
    Pharmacol Biochem Behav; 2020 Oct; 197():173013. PubMed ID: 32758524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of cannabinoid type 1 receptor and 2-arachidonoyl glycerol synthesizing/degrading enzymes is altered in basal ganglia during the active phase of levodopa-induced dyskinesia.
    Rojo-Bustamante E; Abellanas MA; Clavero P; Thiolat ML; Li Q; Luquin MR; Bezard E; Aymerich MS
    Neurobiol Dis; 2018 Oct; 118():64-75. PubMed ID: 29936234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
    Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
    Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autopallidotomy: From Colloquial Term to Scientific Theory.
    McCarter SJ; Savica R
    J Parkinsons Dis; 2022; 12(7):2009-2013. PubMed ID: 36120793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranitidine reduced levodopa-induced dyskinesia in a rat model of Parkinson's disease.
    Cui G; Yang X; Wang X; Zhang Z; Yue X; Shi H; Shen X
    Neuropsychiatr Dis Treat; 2014; 10():39-46. PubMed ID: 24379672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease.
    van der Stelt M; Fox SH; Hill M; Crossman AR; Petrosino S; Di Marzo V; Brotchie JM
    FASEB J; 2005 Jul; 19(9):1140-2. PubMed ID: 15894565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of deep brain stimulation on levodopa-induced dyskinesias and striatal oscillatory local field potentials in a rat model of Parkinson's disease.
    Alam M; Capelle HH; Schwabe K; Krauss JK
    Brain Stimul; 2014; 7(1):13-20. PubMed ID: 24126192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease.
    Krack P; Pollak P; Limousin P; Hoffmann D; Xie J; Benazzouz A; Benabid AL
    Brain; 1998 Mar; 121 ( Pt 3)():451-7. PubMed ID: 9549521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered Neuronal Firing Pattern of the Basal Ganglia Nucleus Plays a Role in Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease.
    Li X; Zhuang P; Li Y
    Front Hum Neurosci; 2015; 9():630. PubMed ID: 26635583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Patterns of neuronal activity in the basal ganglia nucleus in parkinsonian patients with levodopa-induced dyskinesia].
    Li XY; Zhuang P; Li YJ
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(23):1607-12. PubMed ID: 19035099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of Parkinson's disease on the functional connectivity of the motor loop of human basal ganglia.
    Rodriguez-Sabate C; Morales I; Monton F; Rodriguez M
    Parkinsonism Relat Disord; 2019 Jun; 63():100-105. PubMed ID: 30833228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
    Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T
    J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia.
    Prescott IA; Liu LD; Dostrovsky JO; Hodaie M; Lozano AM; Hutchison WD
    Neurobiol Dis; 2014 Nov; 71():24-33. PubMed ID: 25116960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pallidal Connectivity Profiling of Stimulation-Induced Dyskinesia in Parkinson's Disease.
    Tsuboi T; Charbel M; Peterside DT; Rana M; Elkouzi A; Deeb W; Ramirez-Zamora A; Lemos Melo Lobo Jofili Lopes J; Almeida L; Zeilman PR; Eisinger RS; Foote KD; Okromelidze L; Grewal SS; Okun MS; Middlebrooks EH
    Mov Disord; 2021 Feb; 36(2):380-388. PubMed ID: 33002233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease.
    Yoo HS; Chung SJ; Chung SJ; Moon H; Oh JS; Kim JS; Hong JY; Ye BS; Sohn YH; Lee PH
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):423-431. PubMed ID: 29075830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of sigma-receptors in levodopa-induced dyskinesia in patients with advanced Parkinson disease: a positron emission tomography study.
    Nimura T; Ando T; Yamaguchi K; Nakajima T; Shirane R; Itoh M; Tominaga T
    J Neurosurg; 2004 Apr; 100(4):606-10. PubMed ID: 15070112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.